INTRAOPERATIVE LYMPHATIC MAPPING AND SELECTIVE CERVICAL LYMPHADENECTOMY FOR EARLY-STAGE MELANOMAS OF THE HEAD AND NECK

被引:247
作者
MORTON, DL
WEN, DR
FOSHAG, LJ
ESSNER, R
COCHRAN, A
机构
[1] John Wayne Cancer Institute, Saint John's Hospital, Health Center, Santa Monica, CA
[2] John Wayne Cancer Institute, Saint John's Hospital, Santa Monica, CA 90404
关键词
D O I
10.1200/JCO.1993.11.9.1751
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We developed intraoperative lymphatic mapping with selective lymphadenectomy (SLND) to identify micrometastatic spread of cutaneous melanoma to regional lymph nodes. This study was undertaken to assess the sensitivity and specificity of our technique in patients with clinical stage I (CS-I) melanoma of the head or neck. Potients and Methods: Seventy-two CS-I melanoma patients underwent intraoperative lymphatic mapping of primary cutaneous melanomas located on the head, neck, or upper chest/back draining to the neck. Key (sentinel) cervical lymph nodes in the regional lymphatic drainage basin were identified, selectively excised during SLND, and examined for microscopic evidence of tumor cells. If these sentinel nodes were tumor-negative, the surgery was concluded; if the sentinel nodes were tumor-positive, all nodes in the drainage basin were removed during en bloc lymphadenectomy (LND). Results: Intraoperative lymphatic mapping identified sentinel nodes in 90% of the regional drainage basins. Fifteen percent of these nodes were tumor-positive, indicating the need for LND. There were no false-negative sentinel nodes, and extended follow-up showed no local nodal recurrences in patients whose sentinel-node histology did not indicate the need for LND. Conclusion: Intraoperative lymphatic mapping and SLND is a minimally invasive and highly accurate screening technique for determining which patients with CS-I head and neck melanomas have subclinical node metastases and therefore might benefit from cervical LND. © 1993 by American Society of Clinical Oncology.
引用
收藏
页码:1751 / 1756
页数:6
相关论文
共 18 条
  • [1] OCCULT TUMOR-CELLS IN THE LYMPH-NODES OF PATIENTS WITH PATHOLOGICAL STAGE-I MALIGNANT-MELANOMA - AN IMMUNOHISTOLOGICAL STUDY
    COCHRAN, AJ
    WEN, DR
    MORTON, DL
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (08) : 612 - 618
  • [2] FEE HJ, 1978, SURGERY, V84, P626
  • [3] FISHER SR, 1989, LARYNGOSCOPE, V99, P822
  • [4] RATIONAL APPROACH TO SURGICAL MANAGEMENT OF MELANOMA
    HOLMES, EC
    MOSELEY, HS
    MORTON, DL
    CLARK, W
    ROBINSON, D
    URIST, MM
    [J]. ANNALS OF SURGERY, 1977, 186 (04) : 481 - 490
  • [5] CUTANEOUS MELANOMA OF THE HEAD AND NECK
    LOREE, TR
    SPIRO, RH
    [J]. AMERICAN JOURNAL OF SURGERY, 1989, 158 (04) : 388 - 391
  • [6] PROPHYLACTIC LYMPH-NODE DISSECTION IN CLINICAL STAGE I CUTANEOUS MALIGNANT-MELANOMA - RESULTS OF SURGICAL-TREATMENT IN 1319 PATIENTS
    MILTON, GW
    SHAW, HM
    MCCARTHY, WH
    PEARSON, L
    BALCH, CM
    SOONG, SJ
    [J]. BRITISH JOURNAL OF SURGERY, 1982, 69 (02) : 108 - 111
  • [7] MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
  • [8] IMPROVED LONG-TERM SURVIVAL AFTER LYMPHADENECTOMY OF MELANOMA METASTATIC TO REGIONAL NODES - ANALYSIS OF PROGNOSTIC FACTORS IN 1134 PATIENTS FROM THE JOHN-WAYNE-CANCER-CLINIC
    MORTON, DL
    WANEK, L
    NIZZE, JA
    ELASHOFF, RM
    WONG, JH
    [J]. ANNALS OF SURGERY, 1991, 214 (04) : 491 - 501
  • [9] MORTON DL, 1984, CLINICAL ONCOLOGY MONOGRAPHS, V3, P517
  • [10] EXPERIENCE WITH 998 CUTANEOUS MELANOMAS OF THE HEAD AND NECK OVER 30 YEARS
    OBRIEN, CJ
    COATES, AS
    PETERSENSCHAEFER, K
    SHANNON, K
    THOMPSON, JF
    MILTON, GW
    MCCARTHY, WH
    [J]. AMERICAN JOURNAL OF SURGERY, 1991, 162 (04) : 310 - 314